Skip to content

Giselle Prunell

2 papers in the library · 10 citations · publishing 2023-2025

Papers

Plant-derived compounds and neurodegenerative diseases: Different mechanisms of action with therapeutic potential.

Neuroscience February 6, 2025 Carolina Echeverry, Mariana Pazos, Maximiliano Torres-Pérez et al. 9 citations

Neurodegenerative diseases, whose main risk factor is age, are increasing worldwide as life expectancy rises. Although causes remain unknown in about 90% of cases, oxidative stress, mitochondrial dysfunction, altered proteostasis, and inflammation are key contributors to neuronal death. No cure exists; current therapies only relieve symptoms. This review examines three plant-derived compounds with neuroprotective potential used in folk medicine: quercetin (QCT), cannabidiol (CBD), and N,N-dimethyltryptamine (DMT). Each acts through distinct mechanisms—QCT as an antioxidant, CBD as an anti-inflammatory, and DMT as a promoter of neuroplasticity. The authors suggest that combining these compounds or targeting different disease stages could yield effective treatments.

THE AYAHUASCA’S PSYCHEDELIC COMPONENT DMT POTENTIATES NEURITOGENESIS IN PC12 CELLS

IBRO Neuroscience Reports October 1, 2023 Mariana Pazos, Ignacio Carrera, Giselle Prunell 1 citation

Ayahuasca, a psychedelic beverage from the Amazon rainforest traditionally used for medicinal, spiritual, and cultural purposes, is prepared by boiling the vine Banisteriopsis caapi (containing β-carboline alkaloids) and Psychotria viridis (containing N,N-dimethyltryptamine, DMT). Recent research in the context of a renewed interest in psychedelic studies suggests that ayahuasca may have therapeutic potential for treating depression and substance use disorders, among other conditions.